Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PMV Pharmaceuticals, Inc. (PMVP)
|
Add to portfolio |
|
|
|
| Price: |
$23.11
| | Metrics |
| OS: |
48.5
|
M
| |
-34
|
% ROE
|
| Market cap: |
$1.12
|
B
| |
|
|
|
Net cash:
|
$68.2
|
M
| |
$1.41
|
per share
|
|
EV:
|
$1.05
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
($0.80)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 36.5 | 23.9 | 20.8 | 13.9 |
| General and administrative | 21.8 | 11.0 | 5.9 | 5.0 |
| EBIT | -58.3 | -34.9 | -26.6 | -18.9 |
| Pre-tax income | -57.8 | -34.4 | -25.3 | -17.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | -57.8 | -34.4 | -25.4 | -17.5 |
| |
| Diluted EPS | ($1.28) | ($2.40) | ($8.35) | ($5.82) |
| Shares outstanding (diluted) | 45.1 | 14.4 | 3.0 | 3.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|